The Parole Board of Canada announced on Oct. 11 that day parole has been extended for Peter Pennett, 60. His accomplice in ...

Peter Pennettt, 60, was granted day parole a year ago, which was extended; there are multiple conditions attached to his day ...

A proposed bill would establish a program allowing individuals to opt out of being able to enter any of New Jersey's nearly ...

MELBOURNE, Australia, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore will be participating in a fireside ...

King Charles' words of pride and emotion, expressed during that award ceremony, now carry a bitter irony as the tale of redemption spiraled into a story of relapse and regret.

Drug delivery describes the method and approach to delivering drugs or pharmaceuticals and other xenobiotics to their site of action within an organism, with the goal of achieving a therapeutic ...

Fentanyl is a synthetic opioid that is up to 50 times stronger than heroin and 100 times stronger than morphine, according to the Centers for Disease Control and Prevention ... relapse, Luke told her ...

In spite of the fact that chronic circulatory and respiratory conditions engender a significant amount of suffering [1] and cause more deaths among older adults in developed countries than cancer ...

Angeline, A., and P. Perumaloo. From evolution to prevention of adverse drug reaction. Int J Pharm Pract 5 (2015): 1170-1177. Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older ...

Non-steroidal anti-inflammatory drugs (NSAIDs) such as Bayer (aspirin), Motrin (ibuprofen ... Joint surgery can be considered when severe joint damage and pain interfere with daily activities. Regular ...

This platform contains insights related to the latest global, regional and subregional estimates and trends in drug demand and drug supply in the form of global, regional and sub-regional Key Findings ...

Listener feedback on the c-statistic, atherosclerotic plaque imaging, WATCHMAN implant decisions in the US, and deprescribing are the topics John Mandrola, MD, discusses in this week’s podcast.